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Abstract
Primary rat cerebral astrocyte cultures were grown for 2 weeks in isoosmotic medium (305 mosmol) and then placed in
similar medium with a reduced NaCl concentration. During the first hour of growth in this moderately hypoosmotic medium
(240 mosmol), the cells lose 88% of their taurine contents, 62% of their alanine contents, and 54% of their aspartate contents
while regaining normal volume. Loss of these amino acids accounts for 43% of observed volume regulation. Contents of these
amino acids remain decreased during 24 h of growth in hypoosmotic medium. In contrast, potassium, glutamate, glutamine,
and asparagine contents are not changed, relative to cells in isoosmotic medium, at time points between 1 h and 24 h of
hypoosmotic exposure. The data suggest astrocytes contribute to net loss of amino acids, but not potassium, from brains
exposed to hypoosmotic conditions in situ. ß 1999 Elsevier Science B.V. All rights reserved.
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The brain is protected from osmotically induced
volume changes by various mechanisms. During the
¢rst several hours of hyperosmotic treatment (350^
400 mosmol), brain tissue accumulates inorganic os-
molytes [1,2]. After days of persistent serum hyper-
osmolality, concentrations of organic compounds in-
cluding amino acids and sugar polyols increase in
brain tissue [3^5]. This accumulation of organic os-
molytes is mimicked in cultures of cerebral astrocytes
grown in hyperosmotic medium, suggesting astro-
cytes contribute to the increased content of these
compounds in brain [6^9].
Conversely, hypoosmotic hyponatremia (W240^
250 mosmol) is accompanied by loss of inorganic
ions from the brain parenchyma within a few hours
with little to no change in organic osmolyte content
[3,10]. Reduction in the content of amino acids and
other organic osmolytes occurs over several days of
persistent hypoosmotic exposure [3,10,11]. In con-
trast to the brain in vivo, cultured astrocytes lose
taurine and other amino acids within minutes of a
more extreme hypoosmotic exposure (150^170 mos-
mol) without net loss of inorganic ions [12^14].
These di¡erences between in vivo and in vitro re-
sponses to osmotic swelling may be explained if or-
ganic osmolytes lost from astrocytes in the hypoos-
motic brain are redistributed to the extracellular
space or into other cell types. Alternatively, magni-
tudes of organic and inorganic osmolyte losses from
astrocytes may di¡er between prolonged, moderate
hypoosmotic exposure (characteristic of in vivo stud-
ies) and short-term but more severe hypoosmotic
treatment (typical of culture studies). The purpose
of these experiments was to examine changes in os-
molyte content of cultured astrocytes during a hypo-
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osmotic exposure which is similar in magnitude and
duration to that used in studies of the intact animal.
Pregnant Sprague^Dawley rats were obtained
from Harlan (Indianapolis, IN). Newborn calf se-
rum, minimum essential medium in Earle’s balanced
salts without glutamine (MEM), MEM amino acids
(100U concentration), MEM vitamins (50U concen-
tration), and antibiotic solution (5000 U/ml penicil-
lin, 10 mg/ml streptomycin) were obtained from Life
Science Technology (Grand Island, NY). All other
chemicals were the ¢nest grade available and were
obtained from Sigma Chemical Co. (St. Louis, MO).
All procedures were approved by the Laboratory
Animal Care and Utilization Committee of Wright
State University and conformed to the Guide for the
Care and Use of Laboratory Animals. Primary astro-
cyte cultures were prepared and maintained as pre-
viously described [6,15]. After 2 weeks in vitro,
standard culture medium (305 mosmol) was replaced
by experimental culture medium formulated to have
an osmolality of 305 mosmol (isoosmotic) or 240
mosmol (hypoosmotic). These media had identical
concentrations of amino acids, vitamins, antibiotics,
bicarbonate, and calf serum as standard culture me-
dium. Earle’s balanced salt solution of the experi-
mental medium was made from laboratory reagents
and pyrogen-free distilled water. Hypoosmotic me-
dium was made by reducing the concentration of
NaCl. Cells were harvested before or 1 h, 12 h, or
24 h after exposure to experimental culture medium.
Total intracellular volume and contents of potas-
sium and amino acids were measured in each culture
dish. At the designated times, culture dishes were
rinsed twice with phosphate-bu¡ered saline (PBS)
containing 2.7 mM KCl, 1 mM CaCl2, 0.5 mM
MgCl2, 2.7 mM Na2HPO4, 0.5 mM KH2PO4,
1 mM 3-O-methylglucose (3-OMG), and su⁄cient
NaCl to match the osmolality to that of the exper-
imental medium (pH 7.3). Cultures then were incu-
bated at 37‡C in this same PBS plus 0.5 WCi/ml
[3H]3-OMG and 0.5 WCi/ml [14C]sucrose. After
5 min, the cells were rinsed three times with an
osmotically matched sucrose solution containing
1 mM phloretin, 10 mM Tris-base, and 0.5 mM
Ca(NO3)2. pH was adjusted to 7.3 using nitric acid.
Cells were scraped into 1 ml of 0.6 M HClO4 plus
4 mM CsCl, and the resulting suspension was centri-
fuged for 1 min at 10 000Ug. Protein was determined
in the cell pellet [16]. Amino acid, potassium, and
radioactivity contents were measured in the superna-
tant using HPLC, atomic absorption spectroscopy,
and liquid scintillation spectroscopy, respectively
[12]. Cell volume was de¢ned as the 3-OMG space
indicated by the content of 3H [17] and was corrected
for residual incubation solution using [14C]sucrose as
a marker for extracellular space.
The mean þ S.E.M. volume of cells in standard
culture medium prior to exposure to experimental
medium was 5.3 þ 0.3 Wl/(mg protein) and was not
altered at any time point after medium change
(Fig. 1). Previously, we and others have shown as-
trocytes swollen by exposure to hypoosmotic condi-
tions ranging from 110 mosmol to 170 mosmol reg-
ulate cell volume towards normal within 15^30 min
[18^20]. Consistent with these data, we observed
complete volume recovery 1 h after the start of ex-
posure to 240 mosmol medium. At each time point,
cells incubated in experimental hypoosmotic culture
medium had the same volume as cells incubated in
experimental isoosmotic culture medium.
Intracellular potassium concentration, computed
by dividing the total cellular potassium content by
the total intracellular volume of each culture dish,
was similar at each time point for astrocytes incu-
bated in experimental isoosmotic culture medium.
The mean þ S.E.M. potassium concentrations aver-
aged for all cultures in isoosmotic conditions was
140.8 þ 4.0 mM (n = 40). In the osmotically swollen
brain, loss of sodium and chloride may be the result
of transport to the CSF [10] as extracellular volume
is reduced [21]. However, potassium is likely to be
lost from intracellular compartments. Similar to our
previous reports [12,13], we found no loss of potas-
sium from cultured astrocytes during the ¢rst hour of
hypoosmotic exposure (data not shown). Thus, intra-
cellular potassium concentration returns to its initial
value coincident with the return to normal cellular
volume. Astrocyte potassium content per mg protein
and total protein content of the culture dishes were
not altered at any measured time point during expo-
sure to hypoosmotic culture medium.
Contents of taurine, alanine, and aspartate de-
creased by 88%, 62%, and 54%, respectively within
1 h of hypoosmotic exposure and remained at this
diminished level during the 24 h exposure to exper-
imental hypoosmotic culture medium (Fig. 2). The
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reduction of taurine contents represented a
mean þ S.E.M. change in concentration from 26
mM prior to exposure to experimental medium to
2 mM at the 1 h time point. Reduction in taurine
content accounted for at least 80% of the total amino
acids lost at each time point. Together, taurine, ala-
nine, and aspartate contributed 28 mosmol to the
loss of intracellular osmolytes. In contrast, aspara-
gine, glutamine, and glutamate contents were not
altered by exposure to hypoosmotic experimental
culture medium at any time point. Previous reports
have documented glutamate loss from cultured astro-
cytes during hypoosmotic exposure [22]. The lack of
change in glutamate contents in the present studies
may be due to the moderate hypoosmotic insult used
and the ability of the cells to replenish lost glutamate
by metabolism or transport from experimental cul-
ture medium during the prolonged time course of
these experiments.
The combined loss of taurine, aspartate, and ala-
nine is equivalent to 43% of that required to regain
normal cell volume caused by the experimental de-
crease in extracellular osmolality from 305 mosmol
to 240 mosmol. Taurine contributes to the bulk of
this osmolality loss, accounting for more than one-
third of the total osmolytes needed for complete vol-
ume recovery. Neutral osmolytes such as polyols [23]
and ions other than potassium also may leave the
astrocytes and contribute to the complete volume
regulation observed in these experiments. The amino
acids measured in these studies may leave the cells as
charged or uncharged species. If taurine leaves as an
anion, it must abandon a proton in the cell interior,
thus lowering the intracellular pH. By comparing
intracellular acidi¢cation of astrocytes during hypo-
osmotic (200 mosmol) volume regulation with total
Fig. 1. Cellular volume of astrocytes in isoosmotic medium (sol-
id bars) and hypoosmotic medium (open bars). The time since
growth medium was changed to experimental medium is shown
on the abscissa. Values shown are the mean þ S.E.M. of 7^14
independent determinations. Volumes of cells in isoosmotic me-
dium were not di¡erent at any time point (ANOVA, P = 0.13).
Cells in hypoosmotic medium had similar volumes as cells in
isoosmotic medium at each time point (Student’s t-test,
Ps 0.38).
Fig. 2. Amino acid contents of astrocytes in isoosmotic medium
(solid bars) and hypoosmotic medium (open bars). The time
since growth medium was changed to experimental medium is
shown on the abscissa. (A) Astrocyte contents of alanine (Ala),
asparagine (Asn), and aspartate (Asp). (B) Astrocyte contents
of glutamate (Glu), glutamine (Gln), and taurine (Tau). Notice
the di¡erent ordinate scales in A and B. Values shown are the
mean þ S.E.M. of 7^14 independent determinations. Asterisk in-
dicates mean values signi¢cantly lower than that measured in
isoosmotic culture medium prior to exposure to hypoosmotic
experimental medium (P6 0.05 by ANOVA and post hoc Dun-
nett’s test).
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taurine loss, we estimated one-third of the taurine
leaves the cell as an anion [24]. E¥ux of an obliga-
tory positive counter ion to the taurine anion then
would contribute to the volume regulatory response;
however, the identity of counterions to this loss of
anionic taurine is unknown.
Net taurine loss over the time span of these studies
may be due to increased unidirectional e¥ux or de-
creased unidirectional in£ux. Taurine is thought to
leave astrocytes through hypoosmotic activation of a
passive, di¡usion pathway [25], possibly membrane
anion channels [26]. In contrast, osmotic swelling
of astrocytes does not immediately alter the carrier-
mediated mechanism of taurine accumulation [25].
Since we found that contents of taurine and other
amino acids remain low during prolonged hypoos-
motic exposure, either the taurine e¥ux pathway re-
mains activated despite a return to normal cell vol-
ume or the rate of taurine accumulation is
diminished by prolonged hypoosmotic exposure.
Hypoosmotic exposure in vivo results in loss of
organic osmolytes, including amino acids, only after
several hours [3,11]. In contrast, astrocytes in culture
conditions rapidly lose taurine and other amino acids
following hypoosmotic exposure [7,14]. From the
present data, these cells do not reaccumulate taurine,
alanine, and aspartate for at least 24 h. The rapid
e¥ux of taurine from astrocytes is consistent with
elevations of extracellular taurine concentrations
measured during hypoosmotic conditions in vivo
[27^29]. This elevated extracelluar taurine may de-
crease the rate of further taurine e¥ux and increase
the rate of taurine in£ux by astrocytes. Since trans-
port of taurine from blood to brain is not altered
during hypoosmotic hyponatremia [30], enhanced
unidirectional e¥ux at the blood^brain barrier due
to elevated extracellular concentrations may lead to a
gradual net loss of taurine from the brain over sev-
eral hours.
In summary, these in vitro data indicate cerebral
astrocytes contribute to the loss of taurine and other
amino acids from brains of animals exposed to pro-
longed hypoosmotic hyponatremia. Since cultured
astrocytes do not mobilize potassium in response to
hypoosmotic swelling, they are not likely to contrib-
ute to potassium loss from the osmotically swollen
brain. Other cells such as neurons must contribute to
the loss of potassium observed in situ. This proposed
potassium loss from neurons would lead to mem-
brane depolarization and thus, would be consistent
with increases in excitability and seizure susceptibil-
ity reported for in vitro [31] and in vivo [32] models
of hypoosmotic exposure.
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